Medicale Corp. (MCLE): auditor change — Medicale Corp. dismisses Gries & Associates as auditor, appoints GreenGrowth CPAs

Medicale Corp.

Gries & Associates dismissed effective Oct 18, 2023 after its business was sold to GreenGrowth CPAs.
No disagreements or reportable events existed in audits through June 30, 2023.
Prior Gries reports included a going concern modification about Company's ability to continue.
GreenGrowth CPAs appointed as new independent auditor for fiscal year ending Sep 30, 2023.
Gries provided a letter to the SEC agreeing with the dismissal disclosures.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Medicale Corp. dismissed Gries & Associates, LLC as its auditor.

Action: dismissal
Auditor: Gries & Associates, LLC
Successor: GreenGrowth CPAs

Exact text from the filing

On October 18, 2023, the Board of Directors of Medicale Corp. (the "Company") was informed that Gries & Associates, LLC ("Gries & Associates") had sold its business to GreenGrowth CPAs ("GreenGrowth") and subsequently approved the dismissal of Gries & Associates, LLC ("Gries & Associates") as the Company's independent registered public accounting firm, effective immediately.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Medicale Corp. engaged GreenGrowth CPAs as its auditor.

Action: engagement
Auditor: GreenGrowth CPAs

Exact text from the filing

On October 23, 2023, the Board of Directors of the Company approved the appointment of GreenGrowth as the Company's new independent registered public accounting firm for the fiscal year ending September 30, 2023.

View on SEC.gov

Browse all auditor changes →

Medicale Corp. filing history →

Source: SEC EDGAR

accession 0001683168-23-008755

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.